KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Other Operating Expenses (2017 - 2025)

Cardlytics filings provide 8 years of Other Operating Expenses readings, the most recent being -$320000.0 for Q3 2025.

  • Quarterly Other Operating Expenses changed N/A to -$320000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$520000.0 through Mar 2026, down 109.72% year-over-year, with the annual reading at $4.8 million for FY2025, N/A changed from the prior year.
  • Other Operating Expenses hit -$320000.0 in Q3 2025 for Cardlytics, down from -$200000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $430.3 million in Q4 2022 and bottomed at -$444000.0 in Q1 2022.
  • Average Other Operating Expenses over 4 years is $81.4 million, with a median of $63.1 million recorded in 2021.
  • The largest annual shift saw Other Operating Expenses plummeted 100.89% in 2022 before it skyrocketed 6286.94% in 2023.
  • Cardlytics' Other Operating Expenses stood at $76.1 million in 2021, then skyrocketed by 465.29% to $430.3 million in 2022, then plummeted by 61.5% to $165.7 million in 2023, then plummeted by 100.19% to -$320000.0 in 2025.
  • Per Business Quant, the three most recent readings for CDLX's Other Operating Expenses are -$320000.0 (Q3 2025), -$200000.0 (Q2 2025), and $5.4 million (Q1 2025).